Evotec AG has entered a TargetEEM (Enteroendocrine Mechanisms) research collaboration with Harvard University and Doug Melton, Xander University professor in the Department of Stem Cell and Regenerative Biology. The collaboration aims to identify novel enteroendocrine mechanisms, pathways and signals regulating key metabolic processes that have disease-modifying potential in diabetes.   TargetEEM is comprehensive screening effort by Harvard and Evotec designed to search for novel pathways and ta...